The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019

Amendment of regulation 56 (transitional provisions)U.K.

This section has no associated Explanatory Memorandum

22.  In regulation 56, for “Schedule 12” substitute “ Schedules 12 and 13 ”.

Commencement Information

I1Reg. 22 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1